CREO - Microwave Ablation Feasibility Study

The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.

Trial Details

NCT ID
NCT07817147
Phase
NA
Sponsor
Banner Health
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • EUS-Guided MWA Device
Locations (sample)
  • Gilbert, Arizona, United States|33.35283,-111.78903
  • Los Angeles, California, United States|34.05223,-118.24368
  • Chicago, Illinois, United States|41.85003,-87.65005
  • Rochester, Minnesota, United States|44.02163,-92.4699
  • Knoxville, Tennessee, United States|35.96064,-83.92074

Key Eligibility Criteria

  • Male or female ≥18 years of age
  • Willing and able to provide written informed consent
  • Histologically confirmed locally advanced, unresectable or metastatic cancer (Stage III or IV)
  • At least 1 tumor that is indicated for MWA, and the location of target tumor must be accessible via EUS through the gastric wall (eg, pancreas, liv…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →